7Baggers
 published on: 2025-09-29 15:35:28  newser.com Mon, 29 Sep 2025 20:35:28 GMT
 Published on: 2025-09-29 04:55:34  newser.com Mon, 29 Sep 2025 09:55:34 GMT
 published on: 2025-09-27 21:38:21  newser.com Sun, 28 Sep 2025 02:38:21 GMT
 Published on: 2025-09-27 12:03:49  newser.com Sat, 27 Sep 2025 17:03:49 GMT
 published on: 2025-09-26 09:46:51  newser.com Fri, 26 Sep 2025 14:46:51 GMT
 pharvaris (nasdaq:phvs) sees large volume increase - here's why  MarketBeat Wed, 24 Sep 2025 16:47:34 GMT
 Analysts Set Pharvaris N.V. (NASDAQ:PHVS) Price Target at $34.00  Defense World Mon, 22 Sep 2025 05:09:09 GMT
 published on: 2025-09-20 11:01:35  newser.com Sat, 20 Sep 2025 16:01:35 GMT
 pharvaris (nasdaq:phvs) trading up 8.3% - should you buy?  MarketBeat Mon, 15 Sep 2025 00:22:30 GMT
 pharvaris (nasdaq:phvs) trading up 8.3% - should you buy?  MarketBeat Sun, 14 Sep 2025 07:00:00 GMT
 pharvaris (nasdaq:phvs) trading 8.3% higher - should you buy?  MarketBeat Sun, 14 Sep 2025 06:42:32 GMT
 pharvaris (nasdaq:phvs) shares up 8.3% - here's why  MarketBeat Sat, 13 Sep 2025 18:42:42 GMT
 pharvaris (nasdaq:phvs) trading 8.3% higher - should you buy?  MarketBeat Sat, 13 Sep 2025 07:00:00 GMT
 pharvaris (nasdaq:phvs) shares up 8.3% - still a buy?  MarketBeat Thu, 11 Sep 2025 20:41:18 GMT
 pharvaris (nasdaq:phvs) shares up 8.3% - here's what happened  MarketBeat Thu, 11 Sep 2025 20:41:18 GMT
 pharvaris (nasdaq:phvs) stock price up 5.6% - should you buy?  MarketBeat Sun, 07 Sep 2025 07:00:00 GMT
 published on: 2025-09-05 14:09:39  Newser Fri, 05 Sep 2025 19:09:39 GMT

Pharvaris B.V
(NASDAQ:PHVS) 

PHVS stock logo

Pharvaris is a clinical-stage company focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.

Founded: 2015
CEO: Berndt Modig  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends